Olin News

Are Options Traders Betting on a Big Move in Olin (OLN) Stock?

Zacks Nov 22 20:45

Olin Announces Leadership Transition With New CLO Appointment

TipRanksNov 22 05:32

Olin's New Receivables Purchase Agreement and Financial Shift

TipRanksNov 21 05:51

Express News | Olin Corp - Agreement Has Three-Year Term

BreakingsNov 21 05:17

Express News | Olin Corp - Enters Into $500 Million Receivables Purchase Agreement

BreakingsNov 21 05:16

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 15:13

Olin To Go Ex-Dividend On November 14th, 2024 With 0.2 USD Dividend Per Share

November 12th (Eastern Time) - $Olin(OLN.US)$ is trading ex-dividend on November 14th, 2024.Shareholders of record on November 14th, 2024 will receive 0.2 USD dividend per share on December 13th, 2024

Futu NewsNov 13 09:00

Olin Corporation (NYSE:OLN) Will Pay A US$0.20 Dividend In Three Days

Yahoo FinanceNov 10 20:27

FBI Firearm Background Checks Track Higher Ahead of the U.S. Election

Seeking AlphaNov 4 21:50

Piper Sandler Maintains Olin(OLN.US) With Buy Rating, Cuts Target Price to $51

Futu NewsOct 30 19:31 · Ratings

Olin Is Maintained at Market Perform by BMO Capital

Dow JonesOct 30 00:09 · Ratings

Olin Biology (688319.SH): The proposed additional fundraising will not exceed 0.3 billion yuan.

On October 29, Gelonhui announced that Olin Biotech (688319.SH) disclosed that the total amount of funds raised by the company in this issuance of stocks shall not exceed 175.2929 million yuan (including this amount), not more than 0.3 billion yuan and not more than 20% of the net assets at the end of the most recent year. The net proceeds from the funds raised after deducting the relevant issuance expenses are intended to be invested in the following project: the technical renovation project of the vaccine R&D production base.

Gelonghui FinanceOct 29 22:13

Morgan Stanley Maintains Olin(OLN.US) With Sell Rating, Maintains Target Price $41

Futu NewsOct 29 21:31 · Ratings

Express News | Olin Corp : BMO Cuts Target Price to $47 From $50

BreakingsOct 29 19:04

RBC Capital Maintains Olin(OLN.US) With Buy Rating, Cuts Target Price to $48

Futu NewsOct 29 18:31 · Ratings

Olin Biosciences (688319.SH): The net income in the first three quarters was 4.0259 million yuan, a year-on-year decrease of 86.71%.

Gelonghui October 29th news｜Olin Biology (688319.SH) announced the third quarter report of 2024, the company's revenue for the first three quarters of the year was 0.387 billion yuan, a year-on-year increase of 9.75%; net income attributable to shareholders of listed companies was 4.0259 million yuan, a year-on-year decrease of 86.71%; basic earnings per share were 0.0099 yuan.

Gelonghui FinanceOct 29 16:10

Evaluating Olin: Insights From 6 Financial Analysts

BenzingaOct 29 01:01

Olin Analysts Slash Their Forecasts After Q3 Earnings

BenzingaOct 28 22:53

BofA Securities Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $48

Futu NewsOct 28 22:31 · Ratings

Olin Price Target Cut to $56.00/Share From $57.00 by Keybanc

Dow JonesOct 28 21:17 · Ratings